ACRV
Price
$5.54
Change
-$0.31 (-5.30%)
Updated
Feb 21 closing price
Capitalization
172.5M
31 days until earnings call
DNLI
Price
$20.73
Change
-$0.86 (-3.98%)
Updated
Feb 21 closing price
Capitalization
2.98B
8 days until earnings call
Ad is loading...

ACRV vs DNLI

Header iconACRV vs DNLI Comparison
Open Charts ACRV vs DNLIBanner chart's image
Acrivon Therapeutics
Price$5.54
Change-$0.31 (-5.30%)
Volume$40.7K
Capitalization172.5M
Denali Therapeutics
Price$20.73
Change-$0.86 (-3.98%)
Volume$849.19K
Capitalization2.98B
ACRV vs DNLI Comparison Chart
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. DNLI commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and DNLI is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ACRV: $5.54 vs. DNLI: $20.73)
Brand notoriety: ACRV and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 70% vs. DNLI: 87%
Market capitalization -- ACRV: $172.5M vs. DNLI: $2.98B
ACRV [@Biotechnology] is valued at $172.5M. DNLI’s [@Biotechnology] market capitalization is $2.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 5 bearish.
  • DNLI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ACRV and DNLI are a bad buy in the short-term.

Price Growth

ACRV (@Biotechnology) experienced а +2.21% price change this week, while DNLI (@Biotechnology) price change was -2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ACRV is expected to report earnings on May 13, 2025.

DNLI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.98B) has a higher market cap than ACRV($172M). DNLI YTD gains are higher at: 1.717 vs. ACRV (-7.973). ACRV has higher annual earnings (EBITDA): -84.45M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. ACRV (187M). ACRV has less debt than DNLI: ACRV (4.01M) vs DNLI (52.5M). ACRV (0) and DNLI (0) have equivalent revenues.
ACRVDNLIACRV / DNLI
Capitalization172M2.98B6%
EBITDA-84.45M-496.05M17%
Gain YTD-7.9731.717-464%
P/E RatioN/AN/A-
Revenue00-
Total Cash187M837M22%
Total Debt4.01M52.5M8%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRVDNLI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Ad is loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAUX21.650.04
+0.19%
Morgan Stanley Inst Asia Opp A
MFSIX11.60N/A
N/A
Madison Sustainable Equity I
PXNIX10.93-0.07
-0.64%
Impax International Sust Econ Instl
AVLVX14.51-0.30
-2.03%
Avantis U.S. Large Cap Value Inst
PMEGX60.18-1.28
-2.08%
T. Rowe Price Instl Mid-Cap Equity Gr

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
-5.30%
ALLR - ACRV
48%
Loosely correlated
+1.44%
CDXS - ACRV
37%
Loosely correlated
-1.88%
DAWN - ACRV
35%
Loosely correlated
+1.64%
DNLI - ACRV
34%
Loosely correlated
-3.98%
ABSI - ACRV
34%
Loosely correlated
-4.43%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-3.98%
BEAM - DNLI
58%
Loosely correlated
-8.18%
LGND - DNLI
53%
Loosely correlated
-1.10%
RCKT - DNLI
51%
Loosely correlated
-3.68%
VCYT - DNLI
50%
Loosely correlated
-4.56%
ACLX - DNLI
49%
Loosely correlated
-2.83%
More